AVL-292
mRNA synthesis
In vitro transcription of capped mRNA with modified nucleotides and Poly(A) tail
Tyramide Signal Amplification (TSA)
TSA (Tyramide Signal Amplification), used for signal amplification of ISH, IHC and IC etc.
Phos Binding Reagent Acrylamide
Separation of phosphorylated and non-phosphorylated proteins without phospho-specific antibody
Cell Counting Kit-8 (CCK-8)
A convenient and sensitive way for cell proliferation assay and cytotoxicity assay
SYBR Safe DNA Gel Stain
Safe and sensitive stain for visualization of DNA or RNA in agarose or acrylamide gels.
Inhibitor Cocktails
Protect the integrity of proteins from multiple proteases and phosphatases for different applications.
CC-292(原名AVL-292)是一种口服有效的、高效的不可逆小分子BTK抑制剂,IC50值为0.5 nM,EC50值为8 nM[1]。
B细胞受体(BCR)信号通路通过调节细胞选择、成熟、增殖及抗体生成,在B细胞的命运与功能方面起着重要作用。作为Tec激酶家族中的一种酪氨酸激酶,BTK在BCR信号通路的激酶中是一个独特的治疗靶点。研究发现,人体内BTK基因功能缺失突变会导致X-连锁无丙种球蛋白血症(XLA),其特征为B细胞完全缺失、血清免疫球蛋白含量低及复发性感染,这些特征表明,在B细胞的发展和免疫球蛋白产生的过程中BTK不可缺少。CC-292通过与Cys481残基形成共价键来抑制BTK[2]。
已在免疫印迹分析中检验CC-292的抑制活性,其表明在人幼稚原代B细胞中,CC-292强效抑制自磷酸化。此外,经流式细胞术检测CD69的上调也表明,CD69表达呈剂量依赖性降低,且CC-292体外表达水平增加。人类B细胞共价探针分析及酶联免疫吸附试验(ELISA)量化方法表明,在浓度为10 nM的CC-292中孵育1小时后,BTK的占有率为42%。
进行CC-292体内研究,在胶原诱导性关节炎(CIA)小鼠模型中,CC-292口服给药,结果表明BTK占有率和疾病抑制性呈正相关关系。另外,临床试验评估CC-292,结果表明其半衰期为1.9小时,且对B-NHL、WM及CLL病人有疗效[2]。
参考文献:
[1]. Evans E K, Aslanian S, Karp R, et al. Inhibition of Btk with CC-292 provides early pharmacodynamic assessment of activity in mice and humans[J]. Journal of Pharmacology and Experimental Therapeutics, 2013, 346(2): 219-228.
[2]. Aalipour A, Advani R H. Bruton tyrosine kinase inhibitors: a promising novel targeted treatment for B cell lymphomas[J]. British journal of haematology, 2013, 163(4): 436-443.
Physical Appearance | A solid |
Storage | Store at -20°C |
M.Wt | 423.44 |
Cas No. | 1202757-89-8 |
Formula | C22H22FN5O3 |
Synonyms | AVL292;AVL 292 |
Solubility | ≥21.15 mg/mL in DMSO; insoluble in H2O; ≥4.9 mg/mL in EtOH with gentle warming and ultrasonic |
Chemical Name | N-[3-[[5-fluoro-2-[4-(2-methoxyethoxy)anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide |
SDF | Download SDF |
Canonical SMILES | COCCOC1=CC=C(C=C1)NC2=NC=C(C(=N2)NC3=CC(=CC=C3)NC(=O)C=C)F |
运输条件 | 蓝冰运输或根据您的需求运输。 |
一般建议 | 不同厂家不同批次产品溶解度各有差异,仅做参考。若实验所需浓度过大至产品溶解极限,请添加助溶剂助溶或自行调整浓度。溶液形式一般不宜长期储存,请尽快用完。 |
Description | AVL-292是一种高选择性的、口服有效的小分子Btk抑制剂,IC50值为0.5 nM。 | |||||
靶点 | Btk | |||||
IC50 | 0.5 nM |
质量控制和MSDS
- 批次: